Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 8892458)

Published in Int J Radiat Oncol Biol Phys on September 01, 1996

Authors

M S Williams1, M Burk, C L Loprinzi, M Hill, P J Schomberg, K Nearhood, J R O'Fallon, J A Laurie, T G Shanahan, R L Moore, R E Urias, R R Kuske, R E Engel, W D Eggleston

Author Affiliations

1: Toledo Community Clinical Oncology Program, OH, USA.

Articles citing this

The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer (2006) 2.22

Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr (2014) 2.13

Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract (1999) 1.71

Topical agent therapy for prevention and treatment of radiodermatitis: a meta-analysis. Support Care Cancer (2012) 1.66

Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer (2013) 1.10

Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys (2010) 1.07

Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer (2014) 1.05

Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer (2010) 1.04

An evidence-based review of the 10 most commonly used herbs. West J Med (1999) 0.95

A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy. Am J Clin Oncol (2011) 0.91

A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiat Oncol (2007) 0.78

Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial. Curr Oncol (2013) 0.77

Complementary strategies for the management of radiation therapy side effects. J Adv Pract Oncol (2013) 0.77

Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies. Support Care Cancer (2009) 0.75

A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin Reactions. Antioxidants (Basel) (2015) 0.75

Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast Cancer (Dove Med Press) (2017) 0.75

Practice patterns for the prophylaxis and treatment of acute radiation dermatitis in the United States. Support Care Cancer (2017) 0.75

Articles by these authors

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57

Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88

An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA (1993) 5.43

Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer (1999) 4.65

Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83

Studies on ovulation: IV. Induction of ovulation in the hypophysectomized rabbit by administration of anterior lobe extracts. J Physiol (1931) 3.58

Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology (1999) 3.55

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol (1989) 3.44

Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol (2008) 3.32

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.06

It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol (1994) 3.00

Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95

Energy release in the solar corona from spatially resolved magnetic braids. Nature (2013) 2.90

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst (2001) 2.90

Methodologic lessons learned from hot flash studies. J Clin Oncol (2001) 2.82

Megestrol acetate for the prevention of hot flashes. N Engl J Med (1994) 2.72

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65

Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63

OXYGEN POISONING IN MAMMALS. J Exp Med (1927) 2.53

Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J Exp Med (1984) 2.53

The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation (1997) 2.52

Comparative study of ribosomal ribonucleic acid cistrons in enterobacteria and myxobacteria. J Bacteriol (1967) 2.51

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol (2005) 2.41

An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A (2001) 2.28

Characterization of the deoxyribonucleic acid of various strains of halophilic bacteria. J Bacteriol (1969) 2.27

Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol (1996) 2.27

Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol (1998) 2.24

Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake. BJOG (2014) 2.22

Radiation processing of food. J Am Vet Med Assoc (1992) 2.22

Validity of the term "family doctor": a limited study in Hamilton, Ontario. Can Med Assoc J (1968) 2.19

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol (2000) 2.11

Autonomic blocking properties of Wy 21901. Br J Pharmacol (1970) 2.06

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02

Brain metastases from colorectal carcinoma. The long term survivors. Cancer (1996) 2.01

CHANGES IN CARBON DIOXIDE TENSION AND HYDROGEN ION CONCENTRATION OF THE BLOOD FOLLOWING MULTIPLE PULMONARY EMBOLISM. J Exp Med (1927) 1.95

Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest (1999) 1.95

Pulse pressure compared with other blood pressure indexes in the prediction of 25-year cardiovascular and all-cause mortality rates: The Chicago Heart Association Detection Project in Industry Study. Hypertension (2001) 1.94

Retinal haemorrhages in an infant following RetCam screening for retinopathy of prematurity. Eye (Lond) (2004) 1.93

Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys (1995) 1.88

Base sequence homology and renaturation studies of the deoxyribonucleic acid of extremely halophilic bacteria. J Bacteriol (1969) 1.88

Identifying mutations in duplicated functions in Saccharomyces cerevisiae: recessive mutations in HMG-CoA reductase genes. Genetics (1987) 1.87

African-American mortality at older ages: results of a matching study. Demography (1996) 1.85

Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg (2000) 1.78

A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.77

Management of recurrent meningeal hemangiopericytoma. Cancer (1998) 1.76

Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol (1997) 1.76

National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence. Hypertension (2000) 1.76

Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol (1990) 1.74

Investigation of the gastrointestinal bacterial flora. Clin Gastroenterol (1978) 1.72

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. J Clin Oncol (1992) 1.70

Impact of whooping cough on patients and their families. Br Med J (Clin Res Ed) (1985) 1.68

Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys (1992) 1.67

Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol (1994) 1.67

Pathologic rupture of the spleen in hematologic malignancies: two additional cases. Ann Hematol (1996) 1.66

Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol (1998) 1.65

Isolated local-regional recurrence of breast cancer following mastectomy: radiotherapeutic management. Int J Radiat Oncol Biol Phys (1990) 1.64

Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg (1993) 1.64

Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther (2011) 1.62

Mediating the cultural boundaries between medicine, nursing and management--the central challenge in hospital reform. Health Serv Manage Res (2001) 1.61

Expression of TTK, a novel human protein kinase, is associated with cell proliferation. J Biol Chem (1992) 1.59

THE EFFECT OF MULTIPLE EMBOLI OF THE CAPILLARIES AND ARTERIOLES OF ONE LUNG. J Exp Med (1927) 1.59

Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value. J Neurosurg (1997) 1.58

Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. J Immunol (1995) 1.58

Virus recovery in chicken cells tested with Rous sarcoma cell DNA. Nat New Biol (1972) 1.57

Muscular enlargement and number of fibers in skeletal muscles of rats. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.56

Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg (1993) 1.55

Clock mutations alter developmental timing in Drosophila. Heredity (Edinb) (1990) 1.53

Should children who use cochlear implants wear hearing aids in the opposite ear? Ear Hear (2001) 1.53

Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol (1993) 1.52

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys (1995) 1.51

Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am (2006) 1.50

The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer (1986) 1.50

Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys (1996) 1.50

Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery (2001) 1.48

Breast reconstruction in women treated with radiation therapy for breast cancer: cosmesis, complications, and tumor control. Plast Reconstr Surg (1992) 1.48

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48

Infected pancreatic necrosis and peripancreatic fluid collections: serendipitous response to antibiotics and medical therapy in three patients. Pancreas (1996) 1.47

Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol (1984) 1.46

Diet in the aetiology of cancer: a review. Eur J Cancer (1994) 1.45

2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol (2000) 1.43

Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol (1997) 1.43

[The volumes of the thyroid gland in adults aged 18-65 years in the Czech Republic--determination of the norms]. Vnitr Lek (2006) 1.43

Soy for breast cancer survivors: a critical review of the literature. J Nutr (2001) 1.43

Increasing the proportion of women in academic medicine: one institution's response. Mayo Clin Proc (1999) 1.42

Policies for study monitoring and interim reporting of results. J Clin Oncol (1987) 1.41

Late morbidity following nerve-sparing radical hysterectomy. Gynecol Oncol (2009) 1.41

The Mayo Clinic gamma knife experience: indications and initial results. Mayo Clin Proc (1999) 1.40

An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care (2001) 1.40

KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood (2000) 1.39

Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol (1999) 1.39

A mathematical model of cardiocyte Ca(2+) dynamics with a novel representation of sarcoplasmic reticular Ca(2+) control. Biophys J (2000) 1.39

The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr (1976) 1.39

Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience. Mayo Clin Proc (1994) 1.38

Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J Exp Med (1992) 1.37

Leader protein of encephalomyocarditis virus binds zinc, is phosphorylated during viral infection, and affects the efficiency of genome translation. Virology (2001) 1.37